Summary & Overview
HCPCS J7649: Isoetharine HCl Inhalation Solution, Unit-Dose via DME
HCPCS Level II code J7649 designates isoetharine hydrochloride inhalation solution in a unit-dose format, supplied as an FDA-approved final, non-compounded product and administered through durable medical equipment (DME). This medication code is relevant for billing respiratory bronchodilator therapy provided outside the inpatient acute-care environment, particularly in home and outpatient settings where nebulizers or other DME deliver inhaled therapy. Nationally, accurate use of J7649 affects pharmacy reimbursement, DME service billing, and tracking of bronchodilator utilization across payers.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical and billing context for J7649, including typical sites of service and service type. The publication presents benchmarks and payer coverage considerations, summarizes relevant policy updates that affect HCPCS medication billing, and situates the code within clinical workflows for inhalation therapy administered via DME. Data not available in the input is identified where applicable, and the document focuses on national implications for billing, coding compliance, and operational use of J7649 for inhaled isoetharine unit-dose therapy.
Billing Code Overview
HCPCS Level II code J7649 represents Isoetharine HCl, inhalation solution, FDA-approved final product, non-compounded, administered through durable medical equipment (DME), unit dose form, per milligram. This code is used for billing single-dose inhalation solution of isoetharine when supplied and delivered via DME.
Service Type: Inhalation medication administered through DME
Typical Site of Service: Home or other outpatient settings where durable medical equipment is used for inhalation therapy
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with acute bronchospasm from asthma or chronic obstructive pulmonary disease presenting to an outpatient pulmonary clinic, urgent care, or home health visit requiring inhaled bronchodilator therapy delivered through durable medical equipment (DME). The clinician prescribes J7649 — isoetharine HCl inhalation solution in unit-dose form — for administration via a nebulizer supplied under DME when rapid bronchodilation is needed, the patient cannot use handheld metered-dose inhalers, or prior therapies (albuterol) are contraindicated or ineffective. Workflow: clinician documents respiratory symptoms and objective findings (wheezing, decreased peak flow), selects an appropriate ICD-10 diagnosis, writes the prescription and DME order, and documents medical necessity for a unit-dose inhalation solution. The pharmacy or DME supplier dispenses J7649 in unit-dose vials; nursing or respiratory therapy administers the medication via the patient’s nebulizer per facility or homecare protocols. Treatment response, vital signs, and any adverse effects are recorded; billing uses HCPCS code J7649 with appropriate modifiers for payer adjudication.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |